Wolfe Research analyst Mike Polark downgrades Silk Road Medical (NASDAQ:SILK) from Outperform to Peer Perform.
Wolfe Research Downgrades Silk Road Medical to Peer Perform
Wolfe Research analyst Mike Polark downgrades Silk Road Medical (NASDAQ:SILK) from Outperform to Peer Perform.